Nevro (NVRO) Inventory Turnover Ratio, from fourth quarter 2024 to fourth quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Nevro Corp   (NYSE: NVRO)
 

Nevro Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Nevro Corp inventory turnover ratio, the Nevro Corp 's ability to sell and replace its inventory in the fourth quarter 2024, sequentially increased to 1.17 in the fourth quarter 2024, yet the ratio remained below the average, as NVRO's market remain challenging.Average inventory processing period, for the Nevro in Dec 31 2024 quarter, has decreased to 312 days, compare to 335 days, in the Sep 30 2024 quarter.

Within Healthcare sector 327 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2024, to 1209, from total ranking in the third quarter 2024 at 1472.

NVRO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nevro Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVRO Inventory Turnover Ratio (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Inventory Growth -12.98 % -1.64 % 5 % 6.62 % 19.11 %
Y / Y Cost of Sales Growth 14.51 % -5.88 % 4.75 % -5.37 % -9.52 %
Inventory Turnover Ratio (TTM) 1.17 1.09 1.11 1.11 1.14
NVRO's Total Ranking # 1209 # 1472 # 1743 # 1868 # 1753
Average inventory processing period 311 334 330 330 321
Seq. Inventory Growth -14.24 % -4.51 % 4.39 % 1.78 % -3.06 %
Seq. Cost of Sales Growth 25 % -11.11 % 20 % -14.12 % 2.74 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 143
Healthcare Sector # 328
Overall Market # 1209

Inventory Turnover Ratio Statistics
High Average Low
2.89 1.27 0.75
(Mar 31 2015)   (Dec 31 2015)



NVRO Company Profile >> Back to NVRO Efficiency Comparisons >> Compare NVRO Inventory Turnover Ratio to its Competitors

Financial Statements
Nevro 's Inventories $ 103 Millions Visit NVRO's Balance sheet
Nevro 's Cost of Revenues TTM $ 138 Millions Visit NVRO's Income Statement
What are NVRO's Sales? Visit NVRO's Sales by Segment

Other Inventory Turnover Ratios
Nevro 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NVRO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NVRO's Competitors
Inventory Turnover Ratio for NVRO's Suppliers
Inventory Turnover Ratio for NVRO's Customers

You may also want to know
NVRO's Sales Growth Rates NVRO's Pe Price to earnings ratio NVRO's Receivables Turnover Ratio NVRO's Stock Quote
NVRO's Net Income Growth Rates NVRO's Ps Price to Sales ratio NVRO's Sales per Employee NVRO's Asset Turnover Ratio
NVRO's Net Margin NVRO's Pb Price to Book ratio NVRO's Financial Strength Ratios NVRO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2024 Inventories at quarter ending Dec 31 2024
Transmedics Group Inc   3.66 $ 179.459  Millions$ 49  Millions
3m Company  3.66 $ 15,291.000  Millions$ 4,174  Millions
Iovance Biotherapeutics inc   3.66 $ 123.995  Millions$ 34  Millions
Biofrontera Inc   3.65 $ 21.947  Millions$ 6  Millions
Harvard Apparatus Regenerative Technology Inc   3.64 $ 0.270  Millions$ 0  Millions
Neuronetics Inc   3.63 $ 20.000  Millions$ 6  Millions
Ardelyx inc   3.60 $ 50.556  Millions$ 14  Millions
Brightspring Health Services Inc   3.59 $ 1,675.622  Millions$ 467  Millions
Exelixis Inc   3.58 $ 76.216  Millions$ 21  Millions
Cadre Holdings inc   3.57 $ 333.456  Millions$ 93  Millions
Catalyst Pharmaceuticals Inc   3.55 $ 68.845  Millions$ 19  Millions
Solventum Corporation  3.51 $ 3,172.000  Millions$ 903  Millions
Zeo Scientifix Inc   3.51 $ 0.876  Millions$ 0  Millions
Novocure Limited  3.49 $ 137.181  Millions$ 39  Millions
Prestige Consumer Healthcare Inc   3.43 $ 502.000  Millions$ 146  Millions
Gilead Sciences Inc   3.35 $ 6,251.000  Millions$ 1,865  Millions
Casi Pharmaceuticals inc   3.31 $ 17.391  Millions$ 5  Millions
Sonoma Pharmaceuticals Inc   3.27 $ 8.945  Millions$ 3  Millions
Alpha Teknova Inc   3.27 $ 30.000  Millions$ 9  Millions
Phathom Pharmaceuticals Inc   3.20 $ 7.973  Millions$ 2  Millions
Becton Dickinson And Company  3.19 $ 11,307.000  Millions$ 3,543  Millions
Baxter International Inc   3.18 $ 8,046.000  Millions$ 2,531  Millions
Cannapharmarx Inc   3.15 $ 3.476  Millions$ 1  Millions
Nexgel Inc   3.15 $ 5.000  Millions$ 2  Millions
Myomo Inc   3.12 $ 9.000  Millions$ 3  Millions
Agilent Technologies inc   3.07 $ 3,007.000  Millions$ 981  Millions
Dentsply Sirona Inc   3.05 $ 1,835.000  Millions$ 601  Millions
Mettler toledo International Inc   3.05 $ 1,110.886  Millions$ 365  Millions
Maravai Lifesciences Holdings Inc   3.02 $ 150.876  Millions$ 50  Millions
Amneal Pharmaceuticals Inc   3.01 $ 1,772.478  Millions$ 589  Millions

Date modified: 2026-09-08T15:11:27+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.